Accès ouvert
2026
other
OpenAlex
Hiroki Ishihara, Yuyu Liu, Riu Yamashita, Hironori Fukuda et autres
Supplementary Table 8. Tumor responses in the IO-TKI treatment group
Accès ouvert
2026
other
OpenAlex
Hiroki Ishihara, Yuyu Liu, Riu Yamashita, Hironori Fukuda et autres
Supplementary Table 9. Patient characteristics of the IO-IO treatment group
Accès ouvert
2026
other
OpenAlex
Hiroki Ishihara, Yuyu Liu, Riu Yamashita, Hironori Fukuda et autres
Supplementary Table 7. Univariate and multivariate analyses for PFS and OS in the IO-TKI treatment group
Accès ouvert
2026
other
OpenAlex
Hiroki Ishihara, Yuyu Liu, Riu Yamashita, Hironori Fukuda et autres
Supplementary Table 10. Univariate and multivariate analyses for PFS and OS in the IO-IO treatment group
Accès ouvert
2026
other
OpenAlex
Hiroki Ishihara, Yuyu Liu, Riu Yamashita, Hironori Fukuda et autres
Supplementary Figure 3. Comparison of expression levels of specific angiogenesis-related genes between ccRCC and nccRCC. Expression levels of specific angiogenesis-related genes were lower in nccRCC than in ccRCC.
Accès ouvert
2026
other
OpenAlex
Hiroki Ishihara, Yuyu Liu, Riu Yamashita, Hironori Fukuda et autres
Supplementary Table 5. Tumor responses in the ccRCC and nccRCC groups
Accès ouvert
2026
other
OpenAlex
Hiroki Ishihara, Yuyu Liu, Riu Yamashita, Hironori Fukuda et autres
Supplementary Figure 1. Comparison of survival after ICI combination therapy between the ccRCC and nccRCC groups according to the treatment regimen
Accès ouvert
2026
other
OpenAlex
Hiroki Ishihara, Yuyu Liu, Riu Yamashita, Hironori Fukuda et autres
Supplementary Figure 7. Comparison of TIICs between ccRCC and ChRCC
Accès ouvert
2026
other
OpenAlex
Hiroki Ishihara, Yuyu Liu, Riu Yamashita, Hironori Fukuda et autres
Supplementary Figure 5. Prognostic impact of TIME phenotype in ICI combination therapy
Accès ouvert
2026
other
OpenAlex
Hiroki Ishihara, Yuyu Liu, Riu Yamashita, Hironori Fukuda et autres
Supplementary Table 11. Tumor responses in the IO-IO treatment group
Accès ouvert
2026
other
OpenAlex
Hiroki Ishihara, Yuyu Liu, Riu Yamashita, Hironori Fukuda et autres
Supplementary Table 20. Tumor responses in the ccRCC and PRCC groups
Accès ouvert
2026
other
OpenAlex
Hiroki Ishihara, Yuyu Liu, Riu Yamashita, Hironori Fukuda et autres
Supplementary Table 17. Comparison of the number of tumor-infiltrating immune cells stratified by histopathology